Provided by Tiger Fintech (Singapore) Pte. Ltd.

Illumina

85.69
+0.80000.94%
Post-market: 86.751.06+1.24%19:57 EST
Volume:2.20M
Turnover:188.74M
Market Cap:13.57B
PE:-11.14
High:86.82
Open:85.00
Low:84.09
Close:84.89
Loading ...

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
26 Feb

What Makes Illumina (ILMN) a Long Term Bet?

Insider Monkey
·
25 Feb

ILMN Stock Might Rise From Collaboration With Broad Clinical Labs

Zacks
·
24 Feb

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

PR Newswire
·
24 Feb

Trump's Early Policy Moves Create New Headaches for This Biotech Heavyweight -- Heard on the Street -- WSJ

Dow Jones
·
24 Feb

Sell Rating Issued for Illumina Amid Competitive Threats from Roche’s NGS Platform

TIPRANKS
·
24 Feb

Illumina’s Resilient Market Position Amid Emerging Competition: A Buy Recommendation by Puneet Souda

TIPRANKS
·
23 Feb

Illumina Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
22 Feb

BUZZ-Illumina extends fall as Bernstein flags competition from Roche's device

Reuters
·
22 Feb

Illumina, Broad Clinical Labs Partner to Expedite Single-Cell Research

MT Newswires Live
·
21 Feb

BRIEF-Illumina And Broad Clinical Labs Usher In New Era Of Drug Discovery With Collaboration To Rapidly Scale Single-Cell Solutions

Reuters
·
21 Feb

Illumina and Broad Clinical Labs Usher in New Era of Drug Discovery With Collaboration to Rapidly Scale Single-Cell Solutions

THOMSON REUTERS
·
21 Feb

Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions

PR Newswire
·
21 Feb

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
20 Feb

Cathie Wood Explains AI Growth Catalysts for Illumina (ILMN)

Insider Monkey
·
20 Feb

Grail Inc expected to post a loss of $7.05 a share - Earnings Preview

Reuters
·
19 Feb